nach oben

Erschienen in:

01.10.2003

Diagnosis and treatment of documented infections in neutropenic patients

Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

verfasst von: Dieter Buchheidt, Angelika Böhme, Oliver A. Cornely, Gerd Fätkenheuer, Heinz-Georg Fuhr, Gudula Heussel, Christian Junghanss, Meinolf Karthaus, Olaf Kellner, Winfried V. Kern, Xaver Schiel, Orhan Sezer, Thomas Südhoff, Hubert Szelényi(†)

Erschienen in: Annals of Hematology | Sonderheft 2/2003

Einloggen, um Zugang zu erhalten

Abstract

Approximately 85% of patients with acute leukemia undergoing intensive antileukemic treatment develop infections and/or fever during neutropenic phases; in about 50% of these patients clinical, microbiological or clinical and microbiological evidence of infections can be obtained. The response rate is significantly lower in documented infections than in fever of unknown origin (FUO). Evidence-based recommendations for diagnosis and treatment procedures are presented, reflecting study results and expert opinions.

Allen U, Smith CR, Prober CG (1986) The value of skin biopsies in febrile, neutropenic, immunocompromised children. Am J Dis Child 140:459–461PubMed

Bochud PY, Calandra T, Francioli P (1994) Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 97:256–264PubMed

Buchheidt D, Böhme A, Cornely O, Fätkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern W, Schiel X, Sezer O, Südhoff T, Szelenyi H (2001) Dokumentierte Infektionen bei Neutropenie—Empfehlungen zu Diagnostik und Therapie. Dtsch Med Wochenschr 126:1085–1090CrossRefPubMed

Chirletti P, Barillari P, Sammartino P, Cardi M, Caronna R, Arcese W, Petti C, Stipa V (1993) The surgical choice in neutropenic patients with hematological disorders and acute abdominal complications. Leuk Lymphoma 9:237–241PubMed

Cornely OA, Schirmacher P (2001) Clinical picture: Bacterial translocation in neutropenic sepsis. Lancet 358:1842CrossRefPubMed

Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE (1997) Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis 16:424–436PubMed

Elting LS, Rubenstein EB, Rolston KV, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247–259PubMed

Escande MC, Herbrecht R (1998) Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. Support Care Cancer 6:273–280CrossRefPubMed

Fätkenheuer G, Buchheidt D, Cornely OA, Fuhr HG, Karthaus M, Kisro J, Leithäuser M, Salwender H, Südhoff T, Szelényi H (2003) Central venous catheter (CVC)-related infections in neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0769-z

10.

French G (2003) Safety and tolerability of linezolid. J Antimicrob Chemother 51 (Suppl 2):II45-II53

11.

Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr (1995) Society for Healthcare and Epidemiology of America: Position Paper on Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 459–477

12.

Gorschlüter M, Glasmacher A, Hahn C, Leutner C, Marklein G, Remig J, Schmidt-Wolf IG, Sauerbruch T (2001) Severe abdominal infections in neutropenic patients. Cancer Invest 19:669–677CrossRefPubMed

13.

Gorschlüter M, Glasmacher A, Hahn C, Schakowski F, Ziske C, Molitor E, Marklein G, Sauerbruch T, Schmidt-Wolf IG (2001) Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 33:786–791CrossRefPubMed

14.

Gorschlüter M, Marklein G, Hofling K, Clarenbach R, Baumgartner S, Hahn C, Ziske C, Mey U, Heller R, Eis-Hubinger AM, Sauerbruch T, Schmidt-Wolf IG, Glasmacher A (2002) Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol 117:351–358CrossRefPubMed

15.

Hiddemann W, Maschmeyer G, Link H, Helmerking M, Adam D (1997) Therapy of infections in patients with acute leukemia. Med Klin 92:406–409PubMed

16.

Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730–751CrossRefPubMed

17.

Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL, Young LS (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 25:551–573PubMed

18.

Kern WV, Beyer J, Böhme A, Buchheidt D, Cornely O, Einsele H, Kisro J, Krüger W, Maschmeyer G, Ruhnke M, Schmidt CA, Schwartz S, Szelenyi H (2000) Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology. Dtsch Med Wochenschr 125:1582–1588CrossRefPubMed

19.

Kish MA (2001) Guide to development of practice guidelines. Clin Infect Dis 32:851–854CrossRefPubMed

20.

Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW (2003) Antimicrobial therapy of unexplained fever in neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0764-4

21.

Link H, Maschmeyer G, Meyer P, Hiddemann W, Stille W, Helmerking M, Adam D (1994) Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy. Ann Hematol 69:231–243PubMed

22.

Maschmeyer G (1999) Interventional antimicrobial therapy in febrile neutropenic patients. Diagn Microbiol Infect Dis 34:205–212CrossRefPubMed

23.

Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J (2003) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0765-3

24.

Maschmeyer G, Hiddemann W, Link H, Cornely OA, Buchheidt D, Glass B, Adam D (1997) Management of infections during intensive treatment of hematologic malignancies. Ann Hematol 75:9-16CrossRefPubMed

25.

Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, Schmitt J, Adam D (1994) Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 73:2296–2304PubMed

26.

McFarland LV, Mulligan ME, Kwok RY, Stamm WE (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320:204–210PubMed

27.

Montalban C, Patier JL, Calleja JL, Perales J, Serrano M, Bellas C (1989) Neutropenic enterocolitis during treatment of lymphoproliferative neoplasms. Med Clin (Barc) 93:649–652

28.

Pizzo PA, Ladisch S, Ribichaud K (1980) Treatment of Gram-positive septicemia in cancer patients. Cancer 45:206–207PubMed

29.

Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP (1992) Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 11:675–682PubMed

30.

Seifert H, Cornely O, Seggewiss K, Decker M, Stefanik D, Wisplinghoff H, Fätkenheuer G (2003) Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 41:118–123CrossRefPubMed

31.

Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH (1986) The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 57:603–609PubMed

32.

Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN (1998) Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633–636CrossRefPubMed

33.

Smith PF, Birmingham MC, Noskin GA, Meagher AK, Forrest A, Rayner CR, Schentag JJ (2003) Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Ann Oncol 14:795–801CrossRefPubMed

34.

Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Lee JTJ (1983) Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet 2:1043–1046PubMed

35.

Wade DS, Nava HR, Douglass HOJ (1992) Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 69:17–23PubMed

36.

Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103–1110CrossRefPubMed

37.

Yuen KY, Woo PC, Liang RH, Chiu EK, Chen FF, Wong SS, Lau YL, Ha SY, Peiris JS, Siau H, Chan TK (1998) Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbiol Infect Dis 30:75–81CrossRefPubMed

Titel: Diagnosis and treatment of documented infections in neutropenic patients
Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
verfasst von: Dieter Buchheidt
Angelika Böhme
Oliver A. Cornely
Gerd Fätkenheuer
Heinz-Georg Fuhr
Gudula Heussel
Christian Junghanss
Meinolf Karthaus
Olaf Kellner
Winfried V. Kern
Xaver Schiel
Orhan Sezer
Thomas Südhoff
Hubert Szelényi(†)
Publikationsdatum: 01.10.2003
Verlag: Springer-Verlag
Erschienen in: Annals of Hematology / Ausgabe Sonderheft 2/2003
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-003-0766-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Diagnosis and treatment of documented infections in neutropenic patients

Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2003

Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation

Diagnosis of invasive fungal infections in hematology and oncology

Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients

Antimicrobial therapy of unexplained fever in neutropenic patients

Sepsis in neutropenia

Treatment of fungal infections in hematology and oncology

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Update Innere Medizin